Spire Wealth Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-934
Closed -$29.6K – 2367
2023
Q2
$29.6K Hold
934
– – ﹤0.01% 1419
2023
Q1
$30.9K Hold
934
– – ﹤0.01% 1424
2022
Q4
$30K Hold
934
– – ﹤0.01% 1190
2022
Q3
$33K Hold
934
– – ﹤0.01% 1104
2022
Q2
$38K Sell
934
-934
-50% -$45.4K ﹤0.01% 1403
2022
Q1
$108K Hold
1,868
– – ﹤0.01% 1133
2021
Q4
$110K Buy
+1,868
New +$113K ﹤0.01% 1365

Other funds holding ATEX

Spire Wealth Management's ATEX Position: Q3 2023 in Review

Spire Wealth Management sold out of Anterix (ATEX) in Q3 2023, closing a stake of 934 shares — an estimated $29.6K sold.

Spire Wealth Management first reported a position in ATEX in Q4 2021 and held it in 7 quarters. The position peaked at $110K in Q4 2021. 98 funds tracked by Wall St. Rank hold ATEX as of Q3 2023.

  • Spire Wealth Management reported no remaining Anterix position as of Q3 2023 after selling out during the quarter.
  • Spire Wealth Management sold 934 Anterix shares in Q3 2023, an estimated $29.6K.
  • Spire Wealth Management first reported a position in Anterix in Q4 2021 and held it in 7 quarters.
  • Spire Wealth Management's Anterix position peaked at $110K in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Anterix as of Q3 2023.

Based on Spire Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.